Synthesis and Biomedical Applications of Graphene Oxide–Silver Nanoparticle Nanocomposites
Graphene oxide–silver nanoparticle (GO-AgNPs) nanocomposites synergistically combine the high specific surface area and biocompatibility of graphene oxide with the potent antibacterial and optical properties of silver nanoparticles. This review systematically examines current synthetic strategies—physical, chemical, and biological—and their influence on nanocomposite morphology, loading efficiency, and stability. The biomedical applications of GO-AgNPs are critically analyzed, focusing on antimicrobial activity, anticancer therapy, drug delivery, and biosensing. Mechanistic insights reveal that antimicrobial action involves membrane disruption, oxidative stress, and damage to biomolecules, while anticancer effects are mediated through reactive oxygen species (ROS) generation. The review also addresses challenges such as AgNP aggregation and stability, which are mitigated by GO support. Future directions emphasize the development of multifunctional nanomedicine platforms, with a need for standardized toxicity assessments and scalable synthesis. This comprehensive overview aims to guide further research and clinical translation of GO-AgNPs.